About Thetis Pharmaceuticals
Thetis Pharmaceuticals is a private company based in Deep River, Connecticut. It has reported $15,194,645 raised in seven offerings on Form D since August 2011. Its chief executive is Gary Mathias.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Oct 13, 2026 | $560,300of $1.0M target | 10 | $56,030 | Debt, OptionsRule 506(b) | Form D ↗ |
| Jun 27, 2022 | Jul 11, 2022 | $1,098,320of $2.0M target | 9 | $122K | Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 6, 2018 | Aug 7, 2018 | $795,800of $2.1M target | 8 | $99,475 | Debt, Options, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Jun 17, 2016 | Jun 27, 2016amended Jan 17, 2017 | $4,105,495of $8.0M target | 52 | $78,952 | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 29, 2016 | Feb 11, 2016 | $1,434,000of $4.0M target | 16 | $89,625 | Debt, OptionsRule 506(b) | Form D ↗ |
| Dec 3, 2012 | Dec 18, 2012 | $5,665,730of $7.4M target | 32 | $177K | Equity06 | Form D ↗ |
| Aug 11, 2011 | Aug 26, 2011 | $1,535,000of $1.6M target | 14 | $109K | Debt, Options, Securities on exercise06 | Form D ↗ |
| Total, seven offerings | $15,194,645 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Thetis Pharmaceuticals's Form D filed Oct 13, 2026.
Earlier filings also listed Cynthia Green (director, last listed Jul 2022), David Wurzer (director, last listed Aug 2018), David Wurzer (director, last listed Feb 2016), Alan Mendelson (director, last listed Feb 2016) and Michael Carter (secretary, last listed Dec 2012).